Bayer AG (manufacturing in bulk, primary packaging, secondary packaging, quality control, batch release)

The drug is used for the treatment of venous thromboembolism (VTE) and the prevention of its recurrence in children and adolescents (up to 18 years of age) following initial therapy with other anticoagulants.

Dosage form: suspension, oral

ATC: B01AF01